UNLABELLED: A major predictor of failed liver resection and transplantation is nonalcoholic fatty liver disease (NAFLD). NAFLD is linked to a wide spectrum of diseases including obesity and diabetes that are increasingly prevalent in Western populations. Thus, it is important to develop therapies aimed at improving posthepatectomy outcomes in patients with NAFLD, as well as to improve the evaluation of patients slated for hepatic surgery. Decreased hepatic phosphatidylcholine (PC) content and decreased ratio of hepatic PC to phosphatidylethanolamine (PE) have previously been linked to NAFLD. To determine if decreased hepatic PC/PE could predict survival after hepatectomy, we used mouse models lacking key enzymes in PC biosynthesis, namely, phosphatidylethanolamine N-methyltransferase and hepatic-specific CTP:phosphocholine cytidylyltransferase α. These mice were fed a high-fat diet to induce NAFLD. We then performed a 70% partial hepatectomy and monitored postoperative survival. We identified hepatic PC/PE to be inversely correlated with the development of steatosis and inflammation in the progression of NAFLD. Decreased hepatic PC/PE before surgery was also strongly associated with decreased rates of survival after partial hepatectomy. Choline supplementation to the diet increased hepatic PC/PE in Pemt(-/-) mice with NAFLD, decreased inflammation, and increased the survival rate after partial hepatectomy. CONCLUSION: Decreased hepatic PC/PE is a predictor of NAFLD and survival following partial hepatectomy. Choline supplementation may serve as a potential therapy to prevent the progression of NAFLD and to improve postoperative outcome after liver surgery.
UNLABELLED: A major predictor of failed liver resection and transplantation is nonalcoholic fatty liver disease (NAFLD). NAFLD is linked to a wide spectrum of diseases including obesity and diabetes that are increasingly prevalent in Western populations. Thus, it is important to develop therapies aimed at improving posthepatectomy outcomes in patients with NAFLD, as well as to improve the evaluation of patients slated for hepatic surgery. Decreased hepatic phosphatidylcholine (PC) content and decreased ratio of hepatic PC to phosphatidylethanolamine (PE) have previously been linked to NAFLD. To determine if decreased hepatic PC/PE could predict survival after hepatectomy, we used mouse models lacking key enzymes in PC biosynthesis, namely, phosphatidylethanolamine N-methyltransferase and hepatic-specific CTP:phosphocholine cytidylyltransferase α. These mice were fed a high-fat diet to induce NAFLD. We then performed a 70% partial hepatectomy and monitored postoperative survival. We identified hepatic PC/PE to be inversely correlated with the development of steatosis and inflammation in the progression of NAFLD. Decreased hepatic PC/PE before surgery was also strongly associated with decreased rates of survival after partial hepatectomy. Choline supplementation to the diet increased hepatic PC/PE in Pemt(-/-) mice with NAFLD, decreased inflammation, and increased the survival rate after partial hepatectomy. CONCLUSION: Decreased hepatic PC/PE is a predictor of NAFLD and survival following partial hepatectomy. Choline supplementation may serve as a potential therapy to prevent the progression of NAFLD and to improve postoperative outcome after liver surgery.
Authors: Xia Gao; Jelske N van der Veen; Carlos Fernandez-Patron; Jean E Vance; Dennis E Vance; René L Jacobs Journal: J Lipid Res Date: 2015-06-25 Impact factor: 5.922
Authors: Sean A Newsom; Joseph T Brozinick; Katja Kiseljak-Vassiliades; Allison N Strauss; Samantha D Bacon; Anna A Kerege; Hai Hoang Bui; Phil Sanders; Parker Siddall; Tao Wei; Melissa Thomas; Ming Shang Kuo; Travis Nemkov; Angelo D'Alessandro; Kirk C Hansen; Leigh Perreault; Bryan C Bergman Journal: J Appl Physiol (1985) Date: 2016-03-31
Authors: Gengshu Wu; Liyan Zhang; Tete Li; Azeret Zuniga; Gary D Lopaschuk; Liang Li; René L Jacobs; Dennis E Vance Journal: J Biol Chem Date: 2012-11-25 Impact factor: 5.157
Authors: Tanaporn Khamphaya; Natsasi Chukijrungroat; Vitoon Saengsirisuwan; Kisha A Mitchell-Richards; Marie E Robert; Albert Mennone; Meenakshisundaram Ananthanarayanan; Michael H Nathanson; Jittima Weerachayaphorn Journal: Hepatology Date: 2018-01-02 Impact factor: 17.425
Authors: Nina L Gluchowski; Michel Becuwe; Tobias C Walther; Robert V Farese Journal: Nat Rev Gastroenterol Hepatol Date: 2017-04-21 Impact factor: 46.802
Authors: Jeffrey D Pressly; Margaret Z Gurumani; Javier T Varona Santos; Alessia Fornoni; Sandra Merscher; Hassan Al-Ali Journal: Am J Physiol Cell Physiol Date: 2022-02-02 Impact factor: 4.249
Authors: Kim H H Liss; Shelby E Ek; Andrew J Lutkewitte; Terri A Pietka; Mai He; Priya Skaria; Eric Tycksen; Daniel Ferguson; Valerie Blanc; Mark J Graham; Angela M Hall; Mitchell R McGill; Kyle S McCommis; Brian N Finck Journal: Liver Transpl Date: 2020-10-22 Impact factor: 5.799